Build an AI Patient Risk-Stratification Tool for Outpatient Eligibility

1. 1

   Frame the tool as safe volume expansion

   The value is identifying patients who can safely have a procedure at an ASC instead of a hospital, which expands the ASC's addressable case pool without compromising safety. Frame the product around that outcome for both patient safety and center revenue. This dual benefit (safer decisions, more eligible cases) is the pitch.

2. 2

   Build and validate the risk model

   Train a model on patient factors (comorbidities, age, procedure type, and more) to predict the safety of an outpatient setting, and validate it rigorously against real outcomes. Clinical AI that is not carefully validated is both unsafe and unsellable. Validation and evidence, not just model accuracy, are what let clinicians trust it.

3. 3

   Integrate into pre-op and scheduling workflow

   The tool must surface its risk assessment where the decision is made: pre-operative evaluation and scheduling. Integrate with the EMR and the scheduling system so the recommendation informs case placement in real time. A model that lives outside the workflow does not change decisions.

4. 4

   Earn clinician trust and manage liability

   Surgeons and anesthesiologists own the safety decision, so the tool must support their judgment transparently, not replace it, and you must be clear about liability and the tool's role as decision support. Explainable outputs and clinician control drive adoption. Trust is the adoption bottleneck for clinical AI.

5. 5

   Sell on expanded eligible volume

   Sell to ASCs, management companies, and systems on the additional cases they can safely take in the lower-cost setting, quantified. As payers push more procedures to ASCs, a tool that safely widens eligibility rides that trend. Multi-site operators are the highest-value buyers.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Clinical-AI and data-science teams who can validate risk models and earn clinician trust

Not for: Not for a founder unwilling to invest in rigorous clinical validation, without which the tool is unsafe and unsellable. Not for someone who wants surgical planning or intraoperative guidance, which is a separate card. And not for a team that cannot earn clinician trust, which is the real barrier for clinical-decision AI.